BOSTON CELL STANDARDS INC.
BOSTON, MA · Medtech · Private
System of reference standards and measurement traceability tools for immunohistochemistry (IHC) assay calibration traceable to NIST standards
bostoncellstandards.com →- Grants
- $9.7M
- 10 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $2.4M
- 2 awards · Health and Human S
- #195 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Regulatory Validation of Standardized Clinical Immunohistochemistry Controls | $679,166 | |
| Federal grant | Department of Health and Human Services · Phase II · Regulatory Validation of Standardized Clinical Immunohistochemistry Controls | $1,157,142 | |
| Federal grant | Department of Health and Human Services · Phase II · Regulatory Validation of Standardized Clinical Immunohistochemistry Controls | $477,976 | |
| Federal grant | Department of Health and Human Services · Phase II · Regulatory Validation of Standardized Clinical Laboratory Immunohistochemistry Controls | $749,890 | |
| Federal grant | Department of Health and Human Services · Phase II · Regulatory Validation of Standardized Clinical Laboratory Immunohistochemistry Controls | $1,501,780 | |
| Federal grant | Department of Health and Human Services · Phase II · Regulatory Validation of Standardized Clinical Laboratory Immunohistochemistry Controls | $751,890 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · National Immunohistochemistry Standardization Program - Establishment & Launch | $1,101,356 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · National Immunohistochemistry Standardization Program - Establishment and Launch | $1,999,519 | |
| Federal grant | Department of Health and Human Services · Phase II · National Immunohistochemistry Standardization Program - Establishment & Launch | $898,163 | |
| Federal contract | Department of Health and Human Services · Topic 442: Quantitative Traceable Reference Materials As Mddts For Tissue Biomarkers | $385,889 | |
| Federal contract | Department of Health and Human Services · FY24 SBIR Phase II Rd Contract - Topic 442 Boston Cell Standards, Inc. | $1,995,119 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 192 | TETRAIMAGING LLC | $2.4M | — |
| 193 | EARLYDIAGNOSTICS INC | $2.4M | — |
| 194 | SPATIAL SURGICAL LLC | $2.4M | — |
| 195 | BOSTON CELL STANDARDS INC. | $2.4M | — |
| 196 | EMITECH, INC. | $2.4M | — |
| 197 | Color Health | $2.4M | $263M |
| 198 | DOSEOPTICS LLC | $2.4M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.